WebLeveraged buyout, growth capital. AUM. $16.9 billion [1] Number of employees. 100+ (2024) Website. thl .com. Thomas H. Lee Partners, L.P. is an American private equity firm based … Weband despite the very limited immunogenicity data in non-endemic areas, IXIARO provides a substantial improvement in actual benefit (level II) in the prevention of Japanese encephalitis in children (from 2 months to 18 years of age) in the populations recommended by the High Council for Public Health (HCPH).
Haute Autorité de Santé - IXIARO
WebDec 5, 2024 · Administration. IXIARO is administered intramuscularly. The preferred sites for intramuscular injection are the anterolateral aspect of the thigh in infants 2 to 11 months of age, the anterolateral aspect of the thigh (or the deltoid muscle if muscle mass is adequate) in children 1 to <3 years of age, or the deltoid muscle in individuals 3 years of age and older. WebDec 23, 2024 · Matkailijan terveysopas on THL:n toimittama, suomalaisten asiantuntijoiden kirjoittama opas, joka tarjoaa ajantasaista tietoa erilaisista matkailuterveyteen liittyvistä … cabinet maker red seal
IXIARO suspension for injection - Japanese encephalitis vaccine ...
WebRokotteet A–Ö. Rokotteet ovat lääkevalmisteita, joilla ennaltaehkäistään infektio- ja tartuntatauteja sekä niihin liittyviä jälkitauteja, vammautumisia ja kuolemia. Kun tautia ei … Web5. How to store IXIARO . 6. Contents of the pack and other information . 1. What IXIARO is and what it is used for . IXIARO is a vaccine against the Japanese encephalitis virus. The … WebJul 1, 2011 · Travellers with no previous vaccination against JE who are given the primary vaccination series with IXIARO at a travel clinic prior to their journey to Asia. Exclusion Criteria: - < 18 years of age. Acute disease at the time of enrollment. Pregnancy or lactation. Known immunodeficiency or immune suppressive treatment. cabinet maker rapid city sd